Drug establishmentActive, Registered FY2026FDA warning letter on file
Natuzen Co.,Ltd.
Natuzen Co.,Ltd. is an FDA-registered drug establishment (FEI 3006731547) located in . The facility is active, registered for FY2026. Its most recent FDA inspection on record (2024-11-21) was classified VAI. FDA has issued 1 warning letter(s) to this facility.
FDA warning letter
A warning letter is FDA's formal notice of significant violations that require prompt correction. It can hold up product approvals, trigger import alerts, and put supply agreements at risk until the issues are resolved and FDA closes it out.
Establishment record
Inspection history
FDA record timeline
Combined chronology of the public records shown on this page. FDA coverage varies by dataset and year.
Questions
Is Natuzen Co.,Ltd. registered with the FDA?
Yes. Natuzen Co.,Ltd. is an FDA-registered drug establishment (FEI 3006731547) in . Its current registration status is Active, Registered FY2026.
Has Natuzen Co.,Ltd. received an FDA warning letter?
Yes. FDA issued a warning letter to Natuzen Co.,Ltd.; the most recent is dated May 3, 2024 (CGMP/Finished Pharmaceuticals/Adulterated).
What does Natuzen Co.,Ltd. do?
Natuzen Co.,Ltd.'s FDA-registered operations are: Manufacturing.
Related facilities
Source: FDA public data · status as of 2026-08-22